These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 8058318

  • 1. A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression.
    Kitagawa M, Higashi H, Takahashi IS, Okabe T, Ogino H, Taya Y, Hishimura S, Okuyama A.
    Oncogene; 1994 Sep; 9(9):2549-57. PubMed ID: 8058318
    [Abstract] [Full Text] [Related]

  • 2. Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase.
    Kitagawa M, Okabe T, Ogino H, Matsumoto H, Suzuki-Takahashi I, Kokubo T, Higashi H, Saitoh S, Taya Y, Yasuda H.
    Oncogene; 1993 Sep; 8(9):2425-32. PubMed ID: 8395680
    [Abstract] [Full Text] [Related]

  • 3. Autographa californica nucleopolyhedrovirus infection results in Sf9 cell cycle arrest at G2/M phase.
    Braunagel SC, Parr R, Belyavskyi M, Summers MD.
    Virology; 1998 Apr 25; 244(1):195-211. PubMed ID: 9581791
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of cyclin D1 expression and phosphorylation of retinoblastoma protein by phosmidosine, a nucleotide antibiotic.
    Kakeya H, Onose R, Liu PC, Onozawa C, Matsumura F, Osada H.
    Cancer Res; 1998 Feb 15; 58(4):704-10. PubMed ID: 9485024
    [Abstract] [Full Text] [Related]

  • 5. Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines.
    Nishio K, Ishida T, Arioka H, Kurokawa H, Fukuoka K, Nomoto T, Fukumoto H, Yokote H, Saijo N.
    Anticancer Res; 1996 Feb 15; 16(6B):3387-95. PubMed ID: 9042196
    [Abstract] [Full Text] [Related]

  • 6. G1 cell cycle arrest due to the inhibition of erbB family receptor tyrosine kinases does not require the retinoblastoma protein.
    Gonzales AJ, Fry DW.
    Exp Cell Res; 2005 Feb 01; 303(1):56-67. PubMed ID: 15572027
    [Abstract] [Full Text] [Related]

  • 7. The retinoblastoma gene product is reversibly dephosphorylated and bound in the nucleus in S and G2 phases during hypoxic stress.
    Amellem O, Stokke T, Sandvik JA, Pettersen EO.
    Exp Cell Res; 1996 Aug 25; 227(1):106-15. PubMed ID: 8806457
    [Abstract] [Full Text] [Related]

  • 8. Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AMP-dependent and -independent cell cycles.
    Baptist M, Lamy F, Gannon J, Hunt T, Dumont JE, Roger PP.
    J Cell Physiol; 1996 Feb 25; 166(2):256-73. PubMed ID: 8591985
    [Abstract] [Full Text] [Related]

  • 9. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
    Chen HW, Huang HC.
    Br J Pharmacol; 1998 Jul 25; 124(6):1029-40. PubMed ID: 9720770
    [Abstract] [Full Text] [Related]

  • 10. Regulation of synthesis of p34cdc2 and its homologues and their relationship to p110Rb phosphorylation during cell cycle progression of normal human T cells.
    Lucas JJ, Terada N, Szepesi A, Gelfand EW.
    J Immunol; 1992 Mar 15; 148(6):1804-11. PubMed ID: 1541821
    [Abstract] [Full Text] [Related]

  • 11. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F, Giuliano AE, Law RE, Van Herle AJ.
    Anticancer Res; 2001 Mar 15; 21(1A):413-20. PubMed ID: 11299771
    [Abstract] [Full Text] [Related]

  • 12. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.
    Zhu WY, Jones CS, Kiss A, Matsukuma K, Amin S, De Luca LM.
    Exp Cell Res; 1997 Aug 01; 234(2):293-9. PubMed ID: 9260897
    [Abstract] [Full Text] [Related]

  • 13. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
    Ehmann GL, McLean TI, Bachenheimer SL.
    Virology; 2000 Feb 15; 267(2):335-49. PubMed ID: 10662629
    [Abstract] [Full Text] [Related]

  • 14. Conditional binding to and cell cycle-regulated inhibition of cyclin-dependent kinase complexes by p27Kip1.
    Eblen ST, Fautsch MP, Anders RA, Leof EB.
    Cell Growth Differ; 1995 Aug 15; 6(8):915-25. PubMed ID: 8547220
    [Abstract] [Full Text] [Related]

  • 15. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
    Alexandrow MG, Moses HL.
    J Cell Biochem; 1998 Sep 15; 70(4):528-42. PubMed ID: 9712150
    [Abstract] [Full Text] [Related]

  • 16. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
    Ling YH, el-Naggar AK, Priebe W, Perez-Soler R.
    Mol Pharmacol; 1996 May 15; 49(5):832-41. PubMed ID: 8622633
    [Abstract] [Full Text] [Related]

  • 17. Maitotoxin, a calcium channel activator, inhibits cell cycle progression through the G1/S and G2/M transitions and prevents CDC2 kinase activation in GH4C1 cells.
    Van Dolah FM, Ramsdell JS.
    J Cell Physiol; 1996 Jan 15; 166(1):49-56. PubMed ID: 8557775
    [Abstract] [Full Text] [Related]

  • 18. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
    Deep G, Singh RP, Agarwal C, Kroll DJ, Agarwal R.
    Oncogene; 2006 Feb 16; 25(7):1053-69. PubMed ID: 16205633
    [Abstract] [Full Text] [Related]

  • 19. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y, Buffolino P, Coppock DL.
    Exp Cell Res; 1998 Aug 01; 242(2):381-90. PubMed ID: 9683525
    [Abstract] [Full Text] [Related]

  • 20. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130.
    Mayol X, Garriga J, Graña X.
    Oncogene; 1995 Aug 17; 11(4):801-8. PubMed ID: 7651744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.